About

Xynomic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. The founding executives worked at leading multinational biopharmaceutical companies (Schering, Eli Lilly, Merck, and Roche) in R&D roles. The founders also had successful entrepreneurial experiences including founding, building, and exiting successful US-China biopharmaceutical companies.Xynomic Pharma aims to build a comprehensive clinical and pre-clinical stage oncology pipeline targeting cancers with high prevalence in China, US and rest of the world. Xynomic Pharma leverages global resources, enabling the company to develop drugs in a cost and time-efficient manner.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for Bison Capital Acquisition Corp?
What is the 52-week low for Bison Capital Acquisition Corp?
What is Bison Capital Acquisition Corp stock price today?
What was Bison Capital Acquisition Corp stock price yesterday?
What is the 50-day moving average of Bison Capital Acquisition Corp?

Advertisement|Remove ads.